Published in Arterioscler Thromb Vasc Biol on November 15, 2012
Lipid rafts as a membrane-organizing principle. Science (2010) 13.48
Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest (1993) 9.56
Revitalizing membrane rafts: new tools and insights. Nat Rev Mol Cell Biol (2010) 5.03
Role of prostacyclin in the cardiovascular response to thromboxane A2. Science (2002) 4.59
Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies. Biochim Biophys Acta (2007) 3.83
Palmitoylation of ligands, receptors, and intracellular signaling molecules. Sci STKE (2006) 3.56
Roles of G-protein-coupled receptor dimerization. EMBO Rep (2004) 3.33
High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol (2008) 3.09
Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J Clin Invest (2005) 2.89
COX-2-derived prostacyclin confers atheroprotection on female mice. Science (2004) 2.87
Prostacyclin protects against elevated blood pressure and cardiac fibrosis. Cell Metab (2005) 2.82
G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function. Br J Pharmacol (2009) 2.60
ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. J Clin Invest (2011) 2.54
Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med (2001) 2.42
Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice. J Clin Invest (2004) 2.12
Prostanoids in health and disease. J Lipid Res (2008) 2.06
Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function. J Clin Invest (2006) 2.03
Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting. J Biol Chem (2004) 2.03
Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default. Mol Biol Cell (2001) 2.02
Selective stimulation of caveolar endocytosis by glycosphingolipids and cholesterol. Mol Biol Cell (2004) 1.86
Lipid rafts in health and disease. Biol Cell (2007) 1.81
Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology. Pharmacol Ther (2008) 1.72
Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. J Biol Chem (2002) 1.68
Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling. J Immunol (2011) 1.66
Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. J Biol Chem (1999) 1.66
Scavenger receptor BI modulates platelet reactivity and thrombosis in dyslipidemia. Blood (2010) 1.60
Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease. Biochem Cell Biol (2004) 1.59
Investigation of the effect of the farnesyl protein transferase inhibitor R115777 on isoprenylation and intracellular signalling by the prostacyclin receptor. Br J Pharmacol (2004) 1.45
G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains. Handb Exp Pharmacol (2008) 1.41
Dimerization of the human receptors for prostacyclin and thromboxane facilitates thromboxane receptor-mediated cAMP generation. J Biol Chem (2004) 1.38
Cholesterol-dependent separation of the beta2-adrenergic receptor from its partners determines signaling efficacy: insight into nanoscale organization of signal transduction. J Biol Chem (2008) 1.34
Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal. Arthritis Rheum (2003) 1.32
G-protein-coupled receptors, cholesterol and palmitoylation: facts about fats. J Mol Endocrinol (2009) 1.31
G protein-coupled receptor dimers: functional consequences, disease states and drug targets. Pharmacol Ther (2008) 1.26
Recent advances in bioluminescence resonance energy transfer technologies to study GPCR heteromerization. Curr Opin Pharmacol (2009) 1.13
Effect of cholesterol on production of thromboxane b2 by platelets in vitro. N Engl J Med (1980) 1.13
Local cholesterol increase triggers amyloid precursor protein-Bace1 clustering in lipid rafts and rapid endocytosis. FASEB J (2011) 1.12
Formation of mu-/kappa-opioid receptor heterodimer is sex-dependent and mediates female-specific opioid analgesia. Proc Natl Acad Sci U S A (2010) 1.11
Influence of cholesterol content on red cell membrane viscoelasticity and fluidity. Biophys J (1983) 1.09
Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets. J Biol Chem (1999) 1.07
Mysteries of the cell. Do lipid rafts exist? Science (2011) 1.07
Ligand-induced partitioning of human CXCR1 chemokine receptors with lipid raft microenvironments facilitates G-protein-dependent signaling. Mol Cell Biol (2005) 1.05
The nutritional significance of lipid rafts. Annu Rev Nutr (2009) 1.03
Lipid raft-mediated regulation of G-protein coupled receptor signaling by ligands which influence receptor dimerization: a computational study. PLoS One (2009) 0.98
Thromboxane A2 signalling in humans: a 'Tail' of two receptors. Biochem Soc Trans (2001) 0.97
Differential effect of membrane cholesterol removal on mu- and delta-opioid receptors: a parallel comparison of acute and chronic signaling to adenylyl cyclase. J Biol Chem (2009) 0.96
Revaluation of the role of cholesterol in stabilizing rafts implicated in T cell receptor signaling. Cell Signal (2005) 0.92
Retracted Palmitoylation of the human prostacyclin receptor. Functional implications of palmitoylation and isoprenylation. J Biol Chem (2002) 0.91
Selective cholesterol dynamics between lipoproteins and caveolae/lipid rafts. Biochemistry (2007) 0.91
Adenylyl cyclase type 6 overexpression selectively enhances beta-adrenergic and prostacyclin receptor-mediated inhibition of cardiac fibroblast function because of colocalization in lipid rafts. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.89
Membrane cholesterol is a biomechanical regulator of neutrophil adhesion. Arterioscler Thromb Vasc Biol (2009) 0.88
Inhibitors of cholesterol biosynthesis and the problem of hypercholesterolemia. Ann N Y Acad Sci (1956) 0.88
A new approach for studying GPCR dimers: drug-induced inactivation and reactivation to reveal GPCR dimer function in vitro, in primary culture, and in vivo. Pharmacol Ther (2011) 0.87
Cellular cholesterol enrichment impairs T cell activation and chemotaxis. Mech Ageing Dev (2004) 0.87
Lipid composition of liver plasma membranes isolated from rats fed a high glucose or a high fat diet. J Nutr (1979) 0.86
Effect of high-fat diet on cholesterol distribution in plasma lipoproteins, cholesterol esterifying activity in leucocytes, and erythrocyte membrane components studied: importance of body weight. Am J Clin Nutr (1986) 0.85
Palmitoylation of the TPbeta isoform of the human thromboxane A2 receptor. Modulation of G protein: effector coupling and modes of receptor internalization. Cell Signal (2006) 0.84
Dominant negative actions of human prostacyclin receptor variant through dimerization: implications for cardiovascular disease. Arterioscler Thromb Vasc Biol (2010) 0.84
Uncoupling the dopamine D1-D2 receptor complex: a novel target for antidepressant treatment. Clin Pharmacol Ther (2011) 0.81
Effects of diabetes and high fat-high cholesterol diet on plasma lipid levels and on erythrocyte membrane composition. Atherosclerosis (1982) 0.80
Modulation of platelet [3H] iloprost binding by cholesterol, dibucaine and pentoxifylline. Prog Clin Biol Res (1989) 0.76
COX-2-derived prostacyclin confers atheroprotection on female mice. Science (2004) 2.87
Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J Biol Chem (2007) 2.10
Histone acetyltransferase-dependent chromatin remodeling and the vascular clock. J Biol Chem (2003) 1.77
Interferon gamma attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway. J Biol Chem (2009) 1.60
The G12 family of G proteins as a reporter of thromboxane A2 receptor activity. Mol Pharmacol (2006) 1.53
Dimerization of the human receptors for prostacyclin and thromboxane facilitates thromboxane receptor-mediated cAMP generation. J Biol Chem (2004) 1.38
COX-2 and PGE2-dependent immunomodulation in breast cancer. Prostaglandins Other Lipid Mediat (2011) 1.20
Mammary carcinoma cell derived cyclooxygenase 2 suppresses tumor immune surveillance by enhancing intratumoral immune checkpoint activity. Breast Cancer Res (2013) 1.04
Prostaglandin F2alpha elevates blood pressure and promotes atherosclerosis. Proc Natl Acad Sci U S A (2009) 1.00
Prostacylin receptor activation inhibits proliferation of aortic smooth muscle cells by regulating cAMP response element-binding protein- and pocket protein-dependent cyclin a gene expression. Mol Pharmacol (2003) 0.99
Deletion of cyclooxygenase 2 in mouse mammary epithelial cells delays breast cancer onset through augmentation of type 1 immune responses in tumors. Carcinogenesis (2011) 0.96
Regulation of thromboxane receptor trafficking through the prostacyclin receptor in vascular smooth muscle cells: role of receptor heterodimerization. Arterioscler Thromb Vasc Biol (2006) 0.94
Cyclooxygenase-2-dependent prostacyclin formation and blood pressure homeostasis: targeted exchange of cyclooxygenase isoforms in mice. Circ Res (2009) 0.92
Internalization and recycling of the human prostacyclin receptor is modulated through its isoprenylation-dependent interaction with the delta subunit of cGMP phosphodiesterase 6. J Biol Chem (2006) 0.90
Activation-dependent stabilization of the human thromboxane receptor: role of reactive oxygen species. J Lipid Res (2009) 0.89
Heterodimerization of the alpha and beta isoforms of the human thromboxane receptor enhances isoprostane signaling. Biochem Biophys Res Commun (2006) 0.84
Dominant negative actions of human prostacyclin receptor variant through dimerization: implications for cardiovascular disease. Arterioscler Thromb Vasc Biol (2010) 0.84
Endothelial 12(S)-HETE vasorelaxation is mediated by thromboxane receptor inhibition in mouse mesenteric arteries. Am J Physiol Heart Circ Physiol (2012) 0.82
Biased suppression of TP homodimerization and signaling through disruption of a TM GxxxGxxxL helical interaction motif. J Lipid Res (2013) 0.80